EMERALD ADVISERS, LLC Cytokinetics, Incorporated Transaction History

EMERALD ADVISERS, LLC portfolio value:

$16.50M
portfolio value

EMERALD ADVISERS, LLC quarter portfolio value change:

+23.31%
quarter

Cytokinetics, Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +136.03% 196.3K shares 10.83M $48.45 340.61K
Q2 2022 share Increase 0.00% 144.31K shares 5.67M $39.29 144.31K